Magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid is useful in assessment of tubal patency in a patient with iodine-induced hypothyroidism.
A 32-year-old woman presented for evaluation of primary infertility. Because she had a history of iodine-induced hypothyroidism, conventional hysterosalpingography was contraindicated. Tubal patency was assessed by magnetic resonance imaging (MRI) after infusion of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA). Visualization of the contrast medium in the peritoneal cavity revealed tubal patency. Our case indicates that MRI with gadolinium-diethylenetriamine pentaacetic acid is a safe, simple, and easy way to confirm that at least one tube is patent when a patient is at risk for hysterosalpingography. To our knowledge, this is the first report that tubal patency was diagnosed on MRI.
Furuhashi
M
M
Department of Obstetrics and Gynecology, Handa City Hospital, Aichi, Japan.
Miyabe
Y
Y
Katsumata
Y
Y
Oda
H
H
Imai
N
N
D000328:Adult; D003251:Constriction, Pathologic / Q000175:diagnosis; D003287:Contrast Media; D005184:Fallopian Tube Diseases / Q000175:diagnosis*; D005186:Fallopian Tube Patency Tests; D005187:Fallopian Tubes / Q000473:pathology; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis*; D007247:Infertility, Female / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging
D003287:Contrast Media; D019786:Gadolinium DTPA